ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
RevImmune Advances New COVID-19 Immunotherapy americanpharmaceuticalreview
November 04, 2020RevImmune announced its "ILIAD-7" international randomized controlled Phase 2 trial in patients critically ill with COVID-19, is now enrolling patients at five sites in the U.S. -
RevImmune Announces Phase II Trial of the T-Cell Growth Factor for COVID-19 americanpharmaceuticalreview
July 08, 2020RevImmune has launched the "ILIAD" Phase II trial for treatment of COVID-19.Many COVID-19 clinical trials have focused on decreasing the hyper-inflammatory phase that often occurs in COVID-19 patients and can cause substantial damage.
Pharma Sources Insight January 2025
